Deucravacitinib Shows Superiority in Psoriatic Arthritis Phase 3 Trial
ICS Use Tied to Fewer Exacerbations in Patients With Bronchiectasis and Elevated Blood Eosinophils
Anti-Inflammatory Diets May Help Reduce Risk of Alzheimer Disease–Related Death
Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis
Improving Lupus Care Requires Addressing Social Determinants, Expanding Access: Margrit Wiesendanger, MD, PhD
Equitable Access to Lupus Treatment Essential for Improving Minority Patient Outcomes: Margrit Wiesendanger, MD, PhD
Lupus Treatment Landscape Evolves With Biologics and Emerging Cellular Therapies: Margrit Wiesendanger, MD, PhD
Understanding Lupus Symptoms, Diagnostic Barriers, and Affected Populations: Margrit Wiesendanger, MD, PhD
Promising Advances, Key Gaps in Psoriatic Arthritis Research
Enhancing Diversity, Addressing Racial Disparities in Psoriatic Arthritis Research
Clinical Insights, Strategies for Delivering Equitable Psoriatic Arthritis Care
Challenging Perceptions: Exploring Racial, Ethnic Disparities in Psoriatic Arthritis
Dr Colin Howden Shares Insights on Vonoprazan Therapy Over Lansoprazole
Dr Raj Chovatiya Summarizes Clinical Implications of Type 2 Inflammation
Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape
Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies
Managed Care Approaches to Individualize Treatment of Hereditary Angioedema
From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
Leveraging Biologics and Immunotherapies in the Management of Food Allergies
Reflecting on the Real-World Use of Biologic Therapy in Asthma Management
Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden
Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition
Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches
The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care
Nurse-Led Care Improves Disease Activity in Rheumatoid Arthritis